Archive | March, 2012

Lawsuit Claims Takeda Downplayed Actos Bladder Cancer Risk

A fraud lawsuit filed against Japanese drug-maker Takeda Pharmaceuticals alleges that the company downplayed the link between Actos and bladder cancer risk in order to increase sales.

Read More »

Lead Attorneys Named in Actos Bladder Cancer Litigation

The Actos bladder cancer litigation continues to move forward as the federal judge overseeing the consolidated lawsuits names the lead attorneys for the plaintiffs

Read More »

Will Generic Versions of Actos Be Safer?

Patients who use Actos to treat their Type 2 diabetes may soon be able to purchase generic versions of the drug. Patent protection for the drug is set to expire in August 2012, leaving other companies free to market generic counterparts. While generic forms of Actos may be cheaper, the question remains of whether they […]

Read More »